Doubled in a year, but no doubt these are still cheap ASX shares
The Avita Medical Inc (ASX: AVH) share price has more than doubled over the past year, so it might seem absurd that I'm calling it "cheap".
But the stock is still down more than 70% from its pre-COVID high.
The biotechnology stock makes regenerative products for burns patients. The nature of the sector means supreme patience is required from investors for products to go through all the testing and approval hurdles.
Professional investors are bullish on the future for Avita Medical.
According to CMC Invest, nine out of 10 analysts covering the stock are rating it as an add. Among those, eight think it's a strong buy.
Don't consider selling before profitability, page-114
-
- There are more pages in this discussion • 259 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.07 |
Change
0.170(5.86%) |
Mkt cap ! $209.0M | |||
| Open | High | Low | Value | Volume |
| $3.04 | $3.10 | $3.04 | $1.789M | 583.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 13407 | $3.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.08 | 2746 | 1 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| AVH (ASX) Chart |